SRX11502970 20216 SRP328773 PRJNA747705 Participants who reported ARI-related symptoms were invited to the study clinic to provide mid-turbinate, nasal, and oropharyngeal swab specimens. Conventional two steps RT-PCR whole genome amplification were set up in duplicates using 8 pairs or universal primers. Plasmids containing clonal influenza A and B genome segments from participants in the same cohort were sequenced alongside the influenza samples. Samples and plasmids were sequenced on Miseq. SRS9541633 NA0012484733_S1 20216 WGS VIRAL RNA RT-PCR Illumina MiSeq SRX11502971 20221 SRP328773 PRJNA747705 Participants who reported ARI-related symptoms were invited to the study clinic to provide mid-turbinate, nasal, and oropharyngeal swab specimens. Conventional two steps RT-PCR whole genome amplification were set up in duplicates using 8 pairs or universal primers. Plasmids containing clonal influenza A and B genome segments from participants in the same cohort were sequenced alongside the influenza samples. Samples and plasmids were sequenced on Miseq. SRS9541634 NA0012484733_S2 20221 WGS VIRAL RNA RT-PCR Illumina MiSeq SRX11502972 21145 SRP328773 PRJNA747705 Participants who reported ARI-related symptoms were invited to the study clinic to provide mid-turbinate, nasal, and oropharyngeal swab specimens. Conventional two steps RT-PCR whole genome amplification were set up in duplicates using 8 pairs or universal primers. Plasmids containing clonal influenza A and B genome segments from participants in the same cohort were sequenced alongside the influenza samples. Samples and plasmids were sequenced on Miseq. SRS9541635 NA0012481973_S1 21145 WGS VIRAL RNA RT-PCR Illumina MiSeq SRX11502973 21149 SRP328773 PRJNA747705 Participants who reported ARI-related symptoms were invited to the study clinic to provide mid-turbinate, nasal, and oropharyngeal swab specimens. Conventional two steps RT-PCR whole genome amplification were set up in duplicates using 8 pairs or universal primers. Plasmids containing clonal influenza A and B genome segments from participants in the same cohort were sequenced alongside the influenza samples. Samples and plasmids were sequenced on Miseq. SRS9541636 NA0012481973_S2 21149 WGS VIRAL RNA RT-PCR Illumina MiSeq SRX11502974 20233 SRP328773 PRJNA747705 Participants who reported ARI-related symptoms were invited to the study clinic to provide mid-turbinate, nasal, and oropharyngeal swab specimens. Conventional two steps RT-PCR whole genome amplification were set up in duplicates using 8 pairs or universal primers. Plasmids containing clonal influenza A and B genome segments from participants in the same cohort were sequenced alongside the influenza samples. Samples and plasmids were sequenced on Miseq. SRS9541637 NA0012481996_S1 20233 WGS VIRAL RNA RT-PCR Illumina MiSeq SRX11502975 20240 SRP328773 PRJNA747705 Participants who reported ARI-related symptoms were invited to the study clinic to provide mid-turbinate, nasal, and oropharyngeal swab specimens. Conventional two steps RT-PCR whole genome amplification were set up in duplicates using 8 pairs or universal primers. Plasmids containing clonal influenza A and B genome segments from participants in the same cohort were sequenced alongside the influenza samples. Samples and plasmids were sequenced on Miseq. SRS9541638 NA0012481996_S2 20240 WGS VIRAL RNA RT-PCR Illumina MiSeq SRX11502976 20228 SRP328773 PRJNA747705 Participants who reported ARI-related symptoms were invited to the study clinic to provide mid-turbinate, nasal, and oropharyngeal swab specimens. Conventional two steps RT-PCR whole genome amplification were set up in duplicates using 8 pairs or universal primers. Plasmids containing clonal influenza A and B genome segments from participants in the same cohort were sequenced alongside the influenza samples. Samples and plasmids were sequenced on Miseq. SRS9541639 NA0012485360_S1 20228 WGS VIRAL RNA RT-PCR Illumina MiSeq SRX11502977 20235 SRP328773 PRJNA747705 Participants who reported ARI-related symptoms were invited to the study clinic to provide mid-turbinate, nasal, and oropharyngeal swab specimens. Conventional two steps RT-PCR whole genome amplification were set up in duplicates using 8 pairs or universal primers. Plasmids containing clonal influenza A and B genome segments from participants in the same cohort were sequenced alongside the influenza samples. Samples and plasmids were sequenced on Miseq. SRS9541640 NA0012485360_S2 20235 WGS VIRAL RNA RT-PCR Illumina MiSeq SRX11502978 20229 SRP328773 PRJNA747705 Participants who reported ARI-related symptoms were invited to the study clinic to provide mid-turbinate, nasal, and oropharyngeal swab specimens. Conventional two steps RT-PCR whole genome amplification were set up in duplicates using 8 pairs or universal primers. Plasmids containing clonal influenza A and B genome segments from participants in the same cohort were sequenced alongside the influenza samples. Samples and plasmids were sequenced on Miseq. SRS9541641 NA0012485000_S1 20229 WGS VIRAL RNA RT-PCR Illumina MiSeq SRX11502979 20236 SRP328773 PRJNA747705 Participants who reported ARI-related symptoms were invited to the study clinic to provide mid-turbinate, nasal, and oropharyngeal swab specimens. Conventional two steps RT-PCR whole genome amplification were set up in duplicates using 8 pairs or universal primers. Plasmids containing clonal influenza A and B genome segments from participants in the same cohort were sequenced alongside the influenza samples. Samples and plasmids were sequenced on Miseq. SRS9541642 NA0012485000_S2 20236 WGS VIRAL RNA RT-PCR Illumina MiSeq SRX11502980 20217 SRP328773 PRJNA747705 Participants who reported ARI-related symptoms were invited to the study clinic to provide mid-turbinate, nasal, and oropharyngeal swab specimens. Conventional two steps RT-PCR whole genome amplification were set up in duplicates using 8 pairs or universal primers. Plasmids containing clonal influenza A and B genome segments from participants in the same cohort were sequenced alongside the influenza samples. Samples and plasmids were sequenced on Miseq. SRS9541643 NA0012485228_S1 20217 WGS VIRAL RNA RT-PCR Illumina MiSeq SRX11502981 20222 SRP328773 PRJNA747705 Participants who reported ARI-related symptoms were invited to the study clinic to provide mid-turbinate, nasal, and oropharyngeal swab specimens. Conventional two steps RT-PCR whole genome amplification were set up in duplicates using 8 pairs or universal primers. Plasmids containing clonal influenza A and B genome segments from participants in the same cohort were sequenced alongside the influenza samples. Samples and plasmids were sequenced on Miseq. SRS9541644 NA0012485228_S2 20222 WGS VIRAL RNA RT-PCR Illumina MiSeq SRX11502982 21133 SRP328773 PRJNA747705 Participants who reported ARI-related symptoms were invited to the study clinic to provide mid-turbinate, nasal, and oropharyngeal swab specimens. Conventional two steps RT-PCR whole genome amplification were set up in duplicates using 8 pairs or universal primers. Plasmids containing clonal influenza A and B genome segments from participants in the same cohort were sequenced alongside the influenza samples. Samples and plasmids were sequenced on Miseq. SRS9541645 NA0012485427_S1 21133 WGS VIRAL RNA RT-PCR Illumina MiSeq SRX11502983 21141 SRP328773 PRJNA747705 Participants who reported ARI-related symptoms were invited to the study clinic to provide mid-turbinate, nasal, and oropharyngeal swab specimens. Conventional two steps RT-PCR whole genome amplification were set up in duplicates using 8 pairs or universal primers. Plasmids containing clonal influenza A and B genome segments from participants in the same cohort were sequenced alongside the influenza samples. Samples and plasmids were sequenced on Miseq. SRS9541646 NA0012485427_S2 21141 WGS VIRAL RNA RT-PCR Illumina MiSeq SRX11502984 21142 SRP328773 PRJNA747705 Participants who reported ARI-related symptoms were invited to the study clinic to provide mid-turbinate, nasal, and oropharyngeal swab specimens. Conventional two steps RT-PCR whole genome amplification were set up in duplicates using 8 pairs or universal primers. Plasmids containing clonal influenza A and B genome segments from participants in the same cohort were sequenced alongside the influenza samples. Samples and plasmids were sequenced on Miseq. SRS9541647 NA0012485440_S1 21142 WGS VIRAL RNA RT-PCR Illumina MiSeq SRX11502985 21146 SRP328773 PRJNA747705 Participants who reported ARI-related symptoms were invited to the study clinic to provide mid-turbinate, nasal, and oropharyngeal swab specimens. Conventional two steps RT-PCR whole genome amplification were set up in duplicates using 8 pairs or universal primers. Plasmids containing clonal influenza A and B genome segments from participants in the same cohort were sequenced alongside the influenza samples. Samples and plasmids were sequenced on Miseq. SRS9541648 NA0012485440_S2 21146 WGS VIRAL RNA RT-PCR Illumina MiSeq SRX11502986 20232 SRP328773 PRJNA747705 Participants who reported ARI-related symptoms were invited to the study clinic to provide mid-turbinate, nasal, and oropharyngeal swab specimens. Conventional two steps RT-PCR whole genome amplification were set up in duplicates using 8 pairs or universal primers. Plasmids containing clonal influenza A and B genome segments from participants in the same cohort were sequenced alongside the influenza samples. Samples and plasmids were sequenced on Miseq. SRS9541649 NA0012484681_S1 20232 WGS VIRAL RNA RT-PCR Illumina MiSeq SRX11502987 20239 SRP328773 PRJNA747705 Participants who reported ARI-related symptoms were invited to the study clinic to provide mid-turbinate, nasal, and oropharyngeal swab specimens. Conventional two steps RT-PCR whole genome amplification were set up in duplicates using 8 pairs or universal primers. Plasmids containing clonal influenza A and B genome segments from participants in the same cohort were sequenced alongside the influenza samples. Samples and plasmids were sequenced on Miseq. SRS9541650 NA0012484681_S2 20239 WGS VIRAL RNA RT-PCR Illumina MiSeq